September 1952


Author Affiliations

By Members of the Research Division, S. B. Penick & Company. Price not given. Pp. 127, with 31 tables. S. B. Penick & Co., 50 Church Street, New York, 1952.

AMA Arch Intern Med. 1952;90(3):424. doi:10.1001/archinte.1952.00240090145019

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


This book is nothing more than an annotated bibliography on bacitracin. It contains a few statements that embrace generalities concerning antibiotic agents which are good. It is obviously a conspicuous effort to make bacitracin look better than it actually is from the standpoint of antibiotic therapy. The volume does not emphasize the nephrotoxic properties of bacitracin which seriously limit the use of this antibiotic in clinical medicine. On the contrary, the nephrotoxicity of this agent is deprecated, and efforts are made in certain portions of the book to explain nephrotoxicity on a basis other than that of the drug itself. Contrary to what is said in this work, bacitracin is hardly the drug of choice in the treatment of amebiasis. It certainly is of little or no value, despite the authors' contentions, in the treatment of ulcerative colitis and in the preoperative preparation of patients for operations on the bowel.

First Page Preview View Large
First page PDF preview
First page PDF preview